Hongfei Ke

772 total citations
17 papers, 582 citations indexed

About

Hongfei Ke is a scholar working on Molecular Biology, Cancer Research and Endocrine and Autonomic Systems. According to data from OpenAlex, Hongfei Ke has authored 17 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Hongfei Ke's work include Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (4 papers) and Neuroscience of respiration and sleep (3 papers). Hongfei Ke is often cited by papers focused on Extracellular vesicles in disease (6 papers), MicroRNA in disease regulation (4 papers) and Neuroscience of respiration and sleep (3 papers). Hongfei Ke collaborates with scholars based in China, United States and Hong Kong. Hongfei Ke's co-authors include Zhen Wang, Danqing Xin, Xili Chu, Tingting Li, Dexiang Liu, Xin Fang, Min Zhang, Zhao Zhan, Shanxiong Chen and Wenzhong Shi and has published in prestigious journals such as ACS Nano, Journal of Controlled Release and IEEE Transactions on Geoscience and Remote Sensing.

In The Last Decade

Hongfei Ke

17 papers receiving 575 citations

Peers

Hongfei Ke
Comparison fields: 5 of 103
  • Molecular Biology 256
  • Neurology 93
  • Cancer Research 92
  • Management, Monitoring, Policy and Law 82
  • Genetics 58
Replace Cheng Fang with:
Cheng Fang China
Zhaoyan Wang China
Jinxiang Cheng China
Weijiang Wu China
Wenwen Gao China
Ruichun Liu China
Motoaki Fujimoto Japan
Yijun Song China
Hyun-Ju Cho South Korea
Cheng Fang China View profile →
Citations per field, relative to Hongfei Ke
Hongfei Ke · 1×
Citations per year, relative to Hongfei Ke
Hongfei Ke · 1×

Countries citing papers authored by Hongfei Ke

Since Specialization
Citations

This map shows the geographic impact of Hongfei Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongfei Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongfei Ke more than expected).

Fields of papers citing papers by Hongfei Ke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongfei Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongfei Ke. The network helps show where Hongfei Ke may publish in the future.

Co-authorship network of co-authors of Hongfei Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Hongfei Ke. A scholar is included among the top collaborators of Hongfei Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongfei Ke. Hongfei Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
# Work Indexed citations
1 10
2 8
3 24
4 41
5 65
6 10
7 9
8 8
9 119
10 23
11 48
12 8
13 38
14 64
15 40
16 38
17 29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026